The Multicenter, Open-Label, Observational LEAD-Ph Study: Real-World Safety and Effectiveness of Liraglutide in Filipino Participants with Type 2 Diabetes.

Jimeno C, Kho S, de Los Santos GK, Buena-Bobis N, Villa M.

Open source

DOI
10.15605/jafes.033.02.02
Published
2018-10-09
Container
J ASEAN Fed Endocr Soc
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.15605/jafes.033.02.02,
  title = {The Multicenter, Open-Label, Observational LEAD-Ph Study: Real-World Safety and Effectiveness of Liraglutide in Filipino Participants with Type 2 Diabetes.},
  author = {Jimeno C and  Kho S and  de Los Santos GK and  Buena-Bobis N and  Villa M.},
  year = {2018},
  journal = {J ASEAN Fed Endocr Soc},
  doi = {10.15605/jafes.033.02.02},
  url = {https://doi.org/10.15605/jafes.033.02.02}
}

RIS

TY  - JOUR
TI  - The Multicenter, Open-Label, Observational LEAD-Ph Study: Real-World Safety and Effectiveness of Liraglutide in Filipino Participants with Type 2 Diabetes.
AU  - Jimeno C
AU  -  Kho S
AU  -  de Los Santos GK
AU  -  Buena-Bobis N
AU  -  Villa M.
PY  - 2018
JO  - J ASEAN Fed Endocr Soc
DO  - 10.15605/jafes.033.02.02
UR  - https://doi.org/10.15605/jafes.033.02.02
ER  - 

APA

C, J., S, K., GK, D. L. S., N, B., & M., V. (2018). The Multicenter, Open-Label, Observational LEAD-Ph Study: Real-World Safety and Effectiveness of Liraglutide in Filipino Participants with Type 2 Diabetes.. J ASEAN Fed Endocr Soc. https://doi.org/10.15605/jafes.033.02.02

Source records